{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:27:50Z","timestamp":1764714470520},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s11940-009-0054-0","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T02:20:56Z","timestamp":1265941256000},"page":"64-69","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of Thyroid Eye Disease"],"prefix":"10.1007","volume":"12","author":[{"given":"Margaret E.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrak M.","family":"Marzban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajeev S.","family":"Kathuria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,13]]},"reference":[{"key":"54_CR1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","volume":"121","author":"GB Bartley","year":"1996","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF, et al.: Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996, 121:284\u2013290.","journal-title":"Am J Ophthalmol"},{"key":"54_CR2","first-page":"477","volume":"92","author":"GB Bartley","year":"1994","unstructured":"Bartley GB: The epidemiological characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc 1994, 92:477\u2013588.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"10","key":"54_CR3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","volume":"12","author":"WM Wiersanga","year":"2002","unstructured":"Wiersanga WM, Bartalena L: Epidemiology and prevention of Graves\u2019 ophthalmopathy. Thyroid 2002, 12(10):855\u2013860.","journal-title":"Thyroid"},{"key":"54_CR4","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2006-1402","volume":"91","author":"N Manji","year":"2006","unstructured":"Manji N, Carr-Smith JD, Boelaert K, et al.: Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab 2006, 91:4873\u20134880.","journal-title":"J Clin Endocrinol Metab"},{"key":"54_CR5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0029-1220935","volume":"41","author":"AK Eckstein","year":"2009","unstructured":"Eckstein AK, Johnson KTM, Thanos M, et al.: Current insights into the pathogenesis of Graves\u2019 orbitopathy [review]. Horm Metab Res 2009, 41:456\u2013464.","journal-title":"Horm Metab Res"},{"key":"54_CR6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.otc.2006.07.008","volume":"39","author":"HB Lee","year":"2006","unstructured":"Lee HB, Rogers IR, Woog JJ: Evaluation and management of Graves\u2019 orbitopathy. Otolaryngol Clin N Am 2006, 39:923\u2013942.","journal-title":"Otolaryngol Clin N Am"},{"issue":"1","key":"54_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1742-1241.2006.01004.x","volume":"61","author":"S Aktaran","year":"2007","unstructured":"Aktaran S, Akarsu E, Araz M, et al.: Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves\u2019 ophthalmopathy. Int J Clin Pract 2007, 61(1):45\u201351.","journal-title":"Int J Clin Pract"},{"key":"54_CR8","doi-asserted-by":"crossref","unstructured":"\u2022Bradley EA, Gower EW, Bradley DJ, et al.: Orbital radiation for Graves ophthalmopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2008, 115:398\u2013409.This article provides a concise review of the available case studies and randomized controlled trials with respect to orbital radiation in TED.","DOI":"10.1016\/j.ophtha.2007.10.028"},{"key":"54_CR9","unstructured":"Chong KKL, Khanna D, Afifiyan NF, et al.: Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology 2009 Oct 7 (Epub ahead of print)."}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-009-0054-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-009-0054-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-009-0054-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:55Z","timestamp":1559437015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-009-0054-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1007\/s11940-009-0054-0","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}